Gamco Investors INC. ET AL Reduces Stock Holdings in PetIQ, Inc. (NASDAQ:PETQ)

Gamco Investors INC. ET AL trimmed its holdings in shares of PetIQ, Inc. (NASDAQ:PETQ) by 1.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 68,465 shares of the company’s stock after selling 1,223 shares during the quarter. Gamco Investors INC. ET AL owned 0.23% of PetIQ worth $1,252,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. FinTrust Capital Advisors LLC lifted its position in PetIQ by 50.2% during the 1st quarter. FinTrust Capital Advisors LLC now owns 2,618 shares of the company’s stock worth $48,000 after acquiring an additional 875 shares during the period. Natixis Advisors L.P. lifted its position in PetIQ by 10.2% during the 4th quarter. Natixis Advisors L.P. now owns 12,038 shares of the company’s stock worth $237,000 after acquiring an additional 1,113 shares during the period. ICA Group Wealth Management LLC acquired a new stake in PetIQ during the 4th quarter worth about $35,000. China Universal Asset Management Co. Ltd. lifted its position in PetIQ by 67.3% during the 1st quarter. China Universal Asset Management Co. Ltd. now owns 5,643 shares of the company’s stock worth $103,000 after acquiring an additional 2,271 shares during the period. Finally, DekaBank Deutsche Girozentrale acquired a new stake in PetIQ during the 4th quarter worth about $50,000. 94.99% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, Benchmark reaffirmed a “buy” rating and set a $30.00 price target on shares of PetIQ in a research report on Friday, May 10th. Four analysts have rated the stock with a buy rating, According to MarketBeat.com, the company has an average rating of “Buy” and an average target price of $29.00.

PetIQ Stock Performance

Shares of PETQ stock traded up $0.44 on Friday, hitting $21.89. The company had a trading volume of 191,088 shares, compared to its average volume of 310,463. The firm has a market cap of $651.23 million, a P/E ratio of 99.50 and a beta of 1.71. The company has a 50-day moving average price of $21.56 and a 200-day moving average price of $19.03. The company has a quick ratio of 1.25, a current ratio of 2.42 and a debt-to-equity ratio of 1.84. PetIQ, Inc. has a twelve month low of $15.09 and a twelve month high of $22.98.

PetIQ (NASDAQ:PETQ) last issued its quarterly earnings data on Wednesday, May 8th. The company reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.34 by $0.17. The business had revenue of $308.44 million during the quarter, compared to analysts’ expectations of $302.16 million. PetIQ had a return on equity of 13.33% and a net margin of 0.66%. As a group, equities research analysts predict that PetIQ, Inc. will post 1.1 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Scott Huff sold 12,117 shares of PetIQ stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $22.19, for a total value of $268,876.23. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 9.62% of the company’s stock.

PetIQ Profile

PetIQ, Inc operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats.